scispace - formally typeset
E

Erwin W. Gelfand

Researcher at University of Colorado Denver

Publications -  679
Citations -  37565

Erwin W. Gelfand is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Immunoglobulin E & T cell. The author has an hindex of 99, co-authored 675 publications receiving 36059 citations. Previous affiliations of Erwin W. Gelfand include University of Colorado Hospital & University of Virginia.

Papers
More filters
Journal ArticleDOI

Migration and accumulation of eosinophils toward regional lymph nodes after airway allergen challenge.

TL;DR: The presence of eosinophils with a different phenotype in the TLN at early time points after allergen challenge of sensitized mice supports their capacity to serve as antigen-presenting cells, sustaining allergic/inflammatory responses in the airways.
Journal Article

Rapamycin inhibits ribosomal protein synthesis and induces G1 prolongation in mitogen-activated T lymphocytes.

TL;DR: It is concluded that RAP primarily induced a G1 prolongation without blocking cell cycle progression of mitogen-activated resting T lymphocytes, and inhibition of protein synthesis caused by the primary inhibition of ribosomal protein mRNA translation probably explains the effect of RAP.
Journal ArticleDOI

Importance of myeloid dendritic cells in persistent airway disease after repeated allergen exposure.

TL;DR: These data suggest that repeated allergen exposure leads to progressive decreases in AHR and allergic inflammation, through decreases in myeloid dendritic cell numbers.
Journal ArticleDOI

T cells expressing specific V beta elements regulate immunoglobulin E production and airways responsiveness in vivo.

TL;DR: It is demonstrated for the first time that T cells with different V beta specificities play a critical role in the in vivo regulation of allergen-specific IgE production and AR.